Stone Ridge Asset Management LLC Corcept Therapeutics Inc Transaction History

Stone Ridge Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 06, 2020	SELL	$12.06 - $16.96 $284,664 - $400,323	-23,604 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$10.41 - $14.66 $15,615 - $21,990	-1,500 Reduced 5.98%	23,604 $334,000
Q2 2019 Aug 06, 2019	BUY	$9.78 - $12.76 $42,054 - $54,868	4,300 Added 20.67%	25,104 $280,000
Q4 2018 Feb 14, 2019	SELL	$11.29 - $17.19 $69,998 - $106,578	-6,200 Reduced 22.96%	20,804 $278,000
Q3 2018 Nov 06, 2018	SELL	$12.27 - $15.65 $26,994 - $34,430	-2,200 Reduced 7.53%	27,004 $379,000
Q1 2018 May 14, 2018	SELL	$14.59 - $25.5 $30,639 - $53,550	-2,100 Reduced 6.71%	29,204 $480,000
Q4 2017 Feb 14, 2018	BUY	$15.77 - $20.72 $493,664 - $648,618	31,304	31,304 $565,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Ridge Asset Management LLC with notifications on news.